IP Library › Assignment 026497/0001
Patent Assignment
Reel/Frame 026497/0001

Assignment of Assignor's Interest

Recorded: 2011-06-24 Pages: 123
Assignor
BIOVITRUM AB (PUBL)
Executed: 2009-11-23
Assignee
PROXIMAGEN NEUROSCIENCE PLC
HODGKIN BUILDING, KING'S COLLEGE, GUY'S CAMPUS, LONDON, SE1 1UL, UNITED KINGDOM
Covered Properties (22)
Certain Aryl-Aliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin Related Diseases
Patent: 6,465,467 →
Application: 09/589,282 →
Pharmaceutical Combination Formulation and Method of Treatment with the Combination
Patent: 6,818,639 →
Application: 09/908,801 →
Publication: US 2002/0068732
Novel Compounds and Their Use
Patent: 6,756,377 →
Application: 09/988,966 →
Publication: US 2002/0103204
Novel Compounds and Their Use
Patent: 6,593,330 →
Application: 09/989,358 →
Publication: US 2002/0147200
Novel Compounds, Their Use and Preparation
Patent: 7,087,750 →
Application: 10/037,110 →
Publication: US 2002/0165251
Arylsulfonamide Compounds
Patent: 7,173,035 →
Application: 10/143,335 →
Publication: US 2003/0149019
New Compounds
Patent: 6,969,710 →
Application: 10/144,677 →
Publication: US 2003/0149020
Bicyclic Sulfonamide Compounds
Patent: 7,144,883 →
Application: 10/167,141 →
Publication: US 2003/0158202
Certain Arylaliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin-Related Diseases
Patent: 7,534,794 →
Application: 10/269,670 →
Publication: US 2003/0092694
Novel Compounds, Their Use and Preparation
Patent: 7,226,925 →
Application: 10/464,422 →
Publication: US 2004/0029888
Pyrimidine Compounds and Their Use
Patent: 7,247,633 →
Application: 10/618,868 →
Publication: US 2004/0014767
Certain Arylaliphatic and Heteroaryl-Aliphatic Piperazinyl Pyrazines and Their Use in the Treatment of Serotonin-Related Diseases
Patent: 7,071,180 →
Application: 10/873,852 →
Publication: US 2004/0242554
New Benzofuran Compounds
Patent: 7,820,675 →
Application: 11/018,019 →
Publication: US 2006/0287291
Novel Compounds, Their Use and Preparation
Patent: 7,524,839 →
Application: 11/057,033 →
Publication: US 2005/0256106
New Compounds
Patent: 7,319,097 →
Application: 11/214,523 →
Publication: US 2005/0288275
Substituted Sulfonamide Compounds Useful for the Prophylaxis and Treatment of Conditions Relating to Obesity, Type Ii Diabetes and/or Disorders of the Central Nervous System
Patent: 7,566,715 →
Application: 11/215,173 →
Publication: US 2006/0009446
Substituted Sulphonamide Compound and Uses Thereof
Patent: 7,582,767 →
Application: 11/447,524 →
Publication: US 2006/0293361
Substituted Naphthalene Sulfonamides
Patent: 7,572,787 →
Application: 11/510,324 →
Publication: US 2007/0066600
4-Substituted Indole and Indoline Compounds
Patent: 7,812,017 →
Application: 11/824,939 →
Publication: US 2008/0032968
Aryl Sulfonamide Compounds for Treating Obesity
Patent: 7,718,650 →
Application: 11/960,045 →
Publication: US 2008/0096873
Benzofuran Compounds
Application: 12/781,355 →
Publication: US 2010/0222330
Benzofuran Compounds
Application: 12/892,765 →
Publication: US 2011/0015185
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jun 20, 2011
From: BIOVITRUM AB
To: BIOVITRUM AB (PUBL)
Reel/Frame 026480/0454 →
Assignment of Assignor's Interest Jun 24, 2011
From: PROXIMAGEN NEUROSCIENCE PLC
To: PROXIMAGEN LIMITED
Reel/Frame 026497/0177 →
Confirmatory License Aug 21, 2019
From: TRUDEAU INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DEITR
Reel/Frame 050119/0070 →